Objective: Hypercholesterolemia has been shown to impair endothelium-mediated, nitric oxide (NO)-dependent responses to acetylcholine (ACh), serotonin, substance P and flow-mediated dilation. We have recently shown that NO contributes to metabolic vasodilation in the human forearm. We sought to determine whether metabolic vasodilation is impaired in healthy subjects with hypercholesterolemia. Methods: We compared the forearm blood flow (FBF) responses to isotonic exercise, ACh and the endotheliumindependent vasodilator sodium nitroprusside in young, otherwise healthy volunteers with hypercholesterolemia and controls before and G after the NO inhibitor N -monomethyl-L-arginine (L-NMMA). FBF was measured using venous occlusion plethysmography. Hypercholesterolemic (n520) and control (n520) subjects were age-and gender-matched. Results: Total cholesterol (6.960.3 vs. 4.660.1 mmol / l, P,0.0001), low density lipoprotein (4.960.4 vs. 2.760.1 mmol / l, P,0.001) and triglyceride (1.360.2 vs. 0.860.1 mmol / l, P50.005) levels were higher in the hypercholesterolemic group. Basal FBF and resistance were similar in the two groups. Hypercholesterolemia impaired the peak FBF response to ACh (11.161.9 vs. 17.662.2 ml / 100 ml / min, P50.03), and reduced the peak response to sodium nitroprusside (6.060.4 vs. 8.160.6 ml / 100 ml / min, P,0.01). However, hypercholesterolemia did not affect peak hyperemic FBF (13.161.0 vs. 13.261.0 ml / 100 ml / min, P51.0) or the FBF volume repayment during the 1 or 5 min after exercise. Resting FBF was reduced by L-NMMA to a similar degree (by 33% vs. 40%, P50.17) in both groups. Although L-NMMA reduced peak hyperemic FBF (by 16% vs. 17%, P50.93) and the volume repaid after exercise in both groups, there were no differences between the two groups. Conclusions: Exercise-induced metabolic vasodilation is in part dependent on NO release. Hypercholesterolemia impairs NO-mediated vasodilation, but is not associated with a reduction in exercise-induced hyperemia. This may indicate that multiple compensatory mechanisms are operative in skeletal muscle metabolic vasodilation.
Introduction
been shown to be associated with endothelial dysfunction, which is usually assessed by endothelium-dependent vasoThe vascular endothelium has been shown in recent motion [2] . Impaired vasodilation in response to stimulated years to play a central role in the regulation of vasomotor release of endothelium-derived nitric oxide (NO) has been tone, and in the prevention of atherosclerosis by inhibiting demonstrated in patients with hypertension, [3] diabetes thrombosis, inflammation and smooth muscle cell prolifermellitus, [4] hyperhomocysteinemia, [5] a history of ation [1] . Numerous risk factors for atherosclerosis have smoking, [6] a family history of coronary artery disease, [7] and is more marked in those with multiple risk factors [8, 9] . Endothelial function also appears to decline with advancing age [10] . Impaired endothelium-dependent NO-mediated vasodi-2. Methods lation has also been documented in hypercholesterolemia in response to acetylcholine (ACh), [11] [12] [13] [14] [19] suggesting that the abnormality is not linked to a Forty subjects (20 control, 20 with hypercholessingle receptor-mediated pathway [2] . This dysfunction terolemia) with a mean age of 26.766.7 years (mean6SD, may occur at an early age and is detectable before the 23 female, 17 male) were recruited by advertisement for onset of overt vascular disease [19] . Improvement of this study. Subjects were defined as hypercholesterolemic endothelial function has been achieved with cholesterolif screening total cholesterol and low density lipoproteinlowering, [17] L-arginine supplementation, [20] the addicholesterol (LDL) levels were above the 75th percentile for tion of essential cofactors of endothelial NO synthase age and gender based on the National Heart Foundation of (eNOS), [21, 22] and reduction of reactive oxygen species, Australia Risk Factor Prevalence Study [38] . Their clinical [23, 24] all of which improve NO bioavailability. characteristics are shown in Table 1 and their lipid profiles Hypercholesterolemia is an important risk factor for in Table 2 . All subjects were screened for cardiovascular atherosclerosis, [25] and its treatment has been shown to risk factors, cardiovascular disease or other major illness improve survival and reduce morbidity in patients with by medical history, physical examination and fasting lipid coronary artery disease [26] . In these trials cholesterolprofile. Subjects were excluded if they had any other risk lowering was also shown to reduce the need for revascufactor for ischemic heart disease (apart from family larization, and more recent studies have shown that this history), cardiovascular disease, major noncardiac disease treatment decreased myocardial ischemia, [27] exerciseor any abnormality on physical examination (including a induced angina, [28] and improved exercise-induced cordiscrepancy of $10 mmHg of blood pressure between the onary vasomotion [29] .
upper limbs). Subjects on cardiovascular medications were Recent evidence suggests that NO is important in the excluded from either group, though females on estrogen regulation of resting skeletal muscle blood flow, [30] in the hyperemia after ischemia [31] and in exercise-induced containing oral contraceptives were included. The study response to this stimulus has already been established in was approved by the National Health and Medical Reour laboratory [35] . search Council of Australia and the Human Research
The study design is indicated in Fig. 1 All subjects were examined in our vascular research 2.4. Drug infusion protocols laboratory in the morning after a light breakfast. The room was temperature controlled at 22-238C, a quiet atmosphere Acetylcholine chloride (ACh, Miochol, Iolab Pharmaprevailed and the lights were dimmed. Subjects were asked ceuticals, Sydney, Australia), an agent which causes vasoto refrain from caffeine containing food and drinks and dilation by release of endothelial-derived NO [30] and alcohol for 12 h before the study. Aspirin and other endothelium-derived hyperpolarizing factor, [39] was innonsteroidal antiinflammatory drugs were forbidden for a fused via the brachial artery for 5 min in a dose of 30 week prior to the study. After 10 min quiet, supine rest a mg / min as previously described [31, 40] . SNP (Faulding, 20-gauge, 5 cm polyethylene catheter (Cook, Brisbane, Melbourne, Australia), a NO donor which results in direct Australia) was introduced under local anesthesia into the vascular smooth muscle relaxation, was administered via brachial artery of the nondominant upper limb. The the brachial artery for 5 min at a rate of 1 mg / min as procedure was carried out under aseptic conditions. The described in previous studies, [31, 40] to assess the rearterial cannula served as an infusion port for vasoactive sponse to an endothelial-independent vasodilator. These agents and enabled blood pressure to be monitored directly drug doses have previously been shown in our laboratory and continuously. In order to establish a stable baseline all not to have systemic effect [40] . Only one dose of each subjects were rested for at least 30 min after arterial line agonist was given in order to optimise the length of the insertion before the first measurement was made. During protocol to allow for all the other measurements required. this time isotonic glucose (5% Dextrose) was infused at a L-NMMA (Clinalfa, Switzerland) inhibits the production rate of 0.4 ml / min intraarterially (the same rate at which of NO by competing with L-arginine for the enzyme NOS all drugs were subsequently infused). [30] . It has been shown in several studies to reduce resting and stimulated FBF by up to 50% [30, 32, [34] [35] [36] and inhibit metabolic vasodilation by between 10 and 50% 2.3. Study design [32] [33] [34] [35] [36] . L-NMMA was infused in a dose of 2 mg / min for at least 10 min, as in previous studies [32, 35] . To determine whether hypercholesterolemia impaired All drugs were diluted in an isotonic glucose solution NO-dependent vasomotion we compared forearm blood (5% Dextrose) and were infused at a rate of 0.4 ml / min flow (FBF) at rest, following isotonic exercise (FHBF), using a syringe pump (Terumo Corporation, Tokyo, G and in response to ACh, SNP and N -momomethyl-LJapan), the same rate as the vehicle infusion during the arginine (L-NMMA) infusions between the two groups.
initial resting and exercise-induced blood flows. Flow was measured using venous occlusion plethysmography. The metabolic stimulus consisted of rhythmic, isotonic exercise at the wrist. Maximal flexion-extension 2.5. Hemodynamic measurements wrist movement at 45 cycles per min was encouraged and timed with a metronome. Reproducibility of FHBF in FBF was measured in the nondominant arm by venous occlusion plethysmography using calibrated mercury-incholesterol levels, LDL:HDL ratio and triglyceride levels silastic strain gauges (Hokanson, Bellevue, WA, USA) and than the control group (Table 2 ). expressed in milliliters per 100 milliliters of forearm tissue per min, as previously described [40] . Forearm vascular 3.1. Resting hemodynamics resistance (expressed as units indicating mmHg / ml / 100 ml of tissue / min) was calculated from mean arterial blood Resting FBF before any intervention was the same in pressure and FBF, while minimum resistance after exercise both groups (2.160.2 vs. 2.160.2, mean6SE, P50.79). was calculated from mean arterial blood pressure and peak
Resting forearm vascular resistance was also similar in the FHBF.
hypercholesterolemic and control groups (45.163.5 vs. To assess resting blood flow, measurements were taken 42.864.4 units, respectively, P50.68). There was no for at least 2 min and an average of a minimum of five difference in mean arterial blood pressure at baseline results were used for analysis. Exercise-induced FHBF was between the two groups (83.162.6 vs. 79.061.6 mmHg, measured continuously for 5 min after the metabolic respectively, P50.19). Infusion of L-NMMA resulted in a stimulus to examine the time course of recovery and similar 3364% reduction of resting FBF in hypercholesvolume of blood repaid during the hyperemic response, terolemic subjects and 4064% reduction in controls (P5 and this commenced immediately after the cessation of 0.17, Fig. 2 ). There was a corresponding 6068% vs. exercise. Short venous occlusion cycles were used for at 82611% increase in resting forearm vascular resistance, least the first minute, with 12 s cycles thereafter. Peak respectively, with L-NMMA (P50.12, Fig. 2 ). Mean FHBF was determined, and usually occurred in the first arterial blood pressure was not affected during these 10-15 s after completion of the workload. The blood measurements by the L-NMMA infusion. volume (''debt'') repaid during the first minute and subsequent 4 min after exercise was calculated from the 3.2. Stimulated endothelium-dependent and independent area-under-the-curve. responses
Lipid measurements
ACh infusion increased resting FBF in both groups, but the increment was less in hypercholesterolemic subjects Total cholesterol, high density lipoprotein (HDL) and compared to controls (P50.03, Fig. 3 ). The percentage triglyceride concentrations were measured enzymatically. change in FBF in response to ACh was also less in LDL was calculated according to the Friedewald formula.
hypercholesterolemic subjects (452692% vs. 7416104%, Lipoprotein (a) [Lp(a)] was measured by a modified P50.04). The FBF response to ACh was attenuated Behring commercial latex enhanced immunoephelometric similarly, by 10% in the hypercholesterolemic group and method. The upper limit reference range in our laboratory by 12% in the control group, by coinfusion with L-NMMA is 300 mg / l. (Fig. 3) , though this reduction did not achieve significance in either group. 2.7. Statistical analysis SNP infusion increased resting FBF in both groups, but the increment was less in the hypercholesterolemic subClinical characteristics are expressed as mean6standard jects compared to controls (P,0.01, Fig. 3 ). The perdeviation. All other measurements are expressed as centage change in resting FBF with SNP was slightly, mean6standard error (SE). Any difference in the frethough not significantly, lower in the hypercholesterolemic quency of clinical characteristics was compared by the subjects (155619% vs. 197618%, P50.11). The FBF Fisher's exact test. Two-sided Student's t-test was used for response to SNP before and after L-NMMA infusion was comparison of paired and unpaired data as appropriate.
assessed in 19 hypercholesterolemic subjects and in 13 Univariate analysis using simple linear regression was used controls, and was not affected by L-NMMA (Fig. 3) . Mean to determine the relation between the dependent variables arterial blood pressure was not affected by either ACh or (FHBF, ACh and SNP FBF responses) and independent SNP infusions. (clinical) variables. Multivariate analysis was performed using multiple linear regression to determine the best 3.3. Metabolic vasodilation combination of predictor variables. Statistical significance was accepted where P,0.05.
Peak FHBF in response to exercise was similar in the hypercholesterolemic and control groups (13.161.0 vs. 13.261.0 ml / 100 ml / min, respectively, P51.0, Fig. 4 ).
Results
The blood volume repaid during the first minute after exercise was also similar in the hypercholesterolemic and The two groups were well matched for age, sex, and control groups (P50.46, Fig. 5 ). The blood volume repaid clinical and morphometric characteristics ( Table 1 ). The during the 5 min after exercise was also similar in both hypercholesterolemic group had higher total and LDLgroups (P50.32, Fig. 5 ). Mean arterial blood pressure and minimum forearm vascular resistance were comparable group (P50.93). Minimum forearm vascular resistance between the groups during exercise (Fig. 4) . Infusion of after exercise was increased after L-NMMA to a similar L-NMMA attenuated peak FHBF and the blood volume extent in the two groups (Fig. 4) . Mean arterial blood repaid during the 1 and 5 min after exercise to a similar pressure following exercise was increased after L-NMMA, extent in both groups (Figs. 4 and 5) . Peak FHBF after but to a greater degree in the hypercholesterolemic subjects exercise was reduced after L-NMMA by 16% in the (P50.03). In hypercholesterolemic subjects mean arterial hypercholesterolemic group and by 17% in the control blood pressure following exercise increased from 83.862.2 both these parameters after inhibition of NO with L-NMMA. Moreover, there was no apparent relationship in our study between lipid parameters and FBF at rest or in response to exercise. Our findings are consistent with those of Creager et al. who observed no reduction in reactive hyperemia after ischemia in hypercholesterolemia, though the responses to methacholine and SNP were diminished [15] . Sorensen et al. also noted no difference in reactive hyperemia after ischemia in hypercholesterolemia, but detected impaired NO-dependent, flow-mediated dilation [19] . The apparent discrepancy between the preservation of resistance vessel function (reactive and functional hyperemia) and the observed conduit vessel dysfunction (flow-mediated dilation) may relate to the dependence of flow-mediated dilation on NO release [41] . However, inhibition of NO production with L-NMMA was not examined in either of hyperemia appears to be more complex [42] . Several responses in both groups. There was a good correlation between these factors may to contribute to these responses including NO-mediated vasodilators (r50.64, P,0.0001). 1 vasodilator prostanoids, metabolites, ATP-sensitive K channels and myogenic factors [35, 42, 43] . the SNP FBF response. The ACh and SNP FBF responses
The findings of the present study extend those of were strongly correlated (r50.64, P,0.0001, Fig. 6 ).
previous related studies [15, 19] by demonstrating that functional hyperemia is preserved in the presence of impaired responses to NO-mediated vasodilators, despite evidence that NO contributes to functional hyperemia in 4. Discussion these subjects. While similar factors, such as accumulation of vasodilator metabolites, may contribute to both reactive This study has demonstrated that although blood flow hyperemia after ischemia and functional hyperemia associresponses to ACh and SNP are impaired in skeletal muscle ated with exercise, there are significant differences bevasculature in young, otherwise healthy hypercholestween these responses. For example, myogenic responses terolemic subjects, resting FBF and metabolic vasodilation are thought to be more important to reactive compared to in response to exercise is preserved. In addition, resting functional hyperemia, and the relative importance of FBF and FHBF were reduced to a similar extent in endothelial factors to these responses may be different hypercholesterolemic subjects and controls when NO [35, 44, 45] . In addition, functional hyperemia is more production was inhibited by infusion of L-NMMA. This physiologically relevant than the response to either issuggests that despite the apparent reduction in NO biochemia or pharmacological stimuli. availability in response to pharmacological probes, funcWhether hypercholesterolemia affected other factors tional hyperemic capacity is not impaired.
involved in metabolic vasodilation has not been addressed by this study. This important physiological function is 4.1. Metabolic vasodilation regulated by a number of overlapping mediators, and inhibition of one may result in compensatory upregulation Recent experimental evidence suggests that hypercholesof another [42, 43] . It has recently been demonstrated in an 1 terolemia is associated with diminished exercise capacity experimental model that while ATP-sensitive K channels and that this is correlated with endothelial dysfunction are critical in coronary vasodilation during exercise, flow [37] . In humans with heart failure Katz et al. demonstrated still increased substantially with exercise [43] . Blockade of 1 a reduction in the NO contribution to resting FBF and ATP-sensitive K channels, followed by blockade of FHBF when compared to controls [34] . In addition, there adenosine receptors, and finally inhibition of NO prois recent evidence in the human coronary circulation that duction resulted in incremental reductions of metabolic pacing-induced metabolic vasodilation is impaired in pavasodilation. With all three mechanisms inhibited both tients with multiple risk factors for atherosclerosis, and flow at rest and during exercise was below control resting that this is associated with attenuated ACh response [9] .
level [43] . Therefore, multiple vasodilator pathways may However, we did not detect any differences in resting FBF need to be inhibited in young, otherwise healthy hyor functional hyperemia in response to exercise in hypercholesterolemic subjects to show a reduction in metapercholesterolemia. We also noted similar reductions in bolic vasodilation. Alternatively, metabolic vasodilation may only be impaired if multiple risk factors for atheroassociated with atherosclerosis and with risk factors for sclerosis are present [8, 9] .
atherosclerosis, such as hypercholesterolemia [2] . These include attenuation of receptor-mediated eNOS activation, 4.2. Pharmacologic responses relative reduction of L-arginine as a substrate for eNOS, decreased eNOS expression, diminished tetrahydrobiopImpaired ACh-induced vasodilation associated with terin availability, and increased destruction of NO by hypercholesterolemia in our study is consistent with previreactive oxygen species [2] . Although alteration of musous investigations utilising receptor-mediated, NO-depencarinic receptor-mediated eNOS stimulation would explain dent vasodilation as a marker of endothelial function. We the reduced ACh FBF response, this does not explain the also demonstrated an impaired vasodilator response to SNP impaired response to the NO donor SNP. As ACh and SNP in hypercholesterolemic subjects. Others have also shown both induce vasodilation by NO-mediated vascular smooth that hypercholesterolemia is associated with reduced remuscle relaxation, increased breakdown of NO would sponse to nitrovasodilators, [14, 15, 19 ] though this has not explain our results. It is also possible that a defect in been a consistent finding [11, 12, 16] . Interestingly, a recent smooth muscle response per se may be responsible for the study in which transient hypertriglyceridemia was induced observed findings. However, it may be that hypercholesin healthy males there was impaired nitroglycerin-induced terolemia may affect more than one of these mechanisms and flow-mediated vasodilation [46] . The abnormal resimultaneously. sponses to agonists that stimulate NO production and release as well as to NO donors suggests that the defect in hypercholesterolemia lies beyond eNOS.
4.4. Study limitations Although L-NMMA attenuated the ACh response in both groups by approximately 10%, this did not achieve signifiAlthough we have demonstrated that NO-dependent cance. These findings in hypercholesterolemia are similar metabolic vasodilation is not impaired in young volunteers to those of Casino et al., however they also found a with hypercholesterolemia, it is possible that older subjects significant reduction in the ACh response with L-NMMA with age related decline in endothelial function, [10] or in their control group [12] . Importantly, the reduction in those with multiple risk factors for atherosclerosis may the NO component of resting FBF and FHBF was condemonstrate impaired NO-dependent metabolic vasodilatsistent in our study, and of similar magnitude to that found ion [9] . in previous studies in which the response to ACh was also Another potential limitation of this study is the inclusion attenuated by L-NMMA [30, 32, 33] . Moreover, the dose of of a small number of women taking estrogen containing L-NMMA used in our study would be expected to inhibit oral contraceptives. Fluctuations in circulating endogenous NO production [30, 32] . It is possible that the impaired estrogen levels has been shown to effect endothelial response to ACh may be due to factors other than NO, as it function [50] . For ethical reasons we did not request has recently been demonstrated that endothelium-derived cessation of that medication for the study. Nevertheless, hyperpolarizing factor-mediated relaxation may be imthe number of women taking oral contraceptives in each paired, and vasoconstrictor prostanoids may be augmented group was similar, and their use did not predict ACh or in hypercholesterolemia in humans [47, 48] . Another possi-SNP FBF responses on univariate analysis. bility is that the design of our study may have limited our ability to detect a reduction in the ACh response after L-NMMA. We used only one dose of ACh on each 4.5. Clinical implications occasion as our primary objective was assessment of metabolic vasodilation, but recent evidence suggests that
The effect of endothelial dysfunction secondary to several doses of ACh are required after NO inhibition to hypercholesterolemia on physiological functions, such as attenuate the response [49] . The inability of L-NMMA to exercise hyperemia, has largely been unexplored, but is of inhibit ACh-mediated vasodilation has been a consistent critical importance to the understanding of ischemic finding in our laboratory in response to a single dose of syndromes. The young hypercholesterolemic subjects in ACh [35] . This suggests that the first dose of ACh may our study, carefully screened to exclude other risk factors only release preformed stores of NO-containing factors and overt atherosclerosis, did not demonstrate reduced from the endothelium [49] . It is possible, therefore, that a metabolic vasodilation despite impaired ACh and SNP dose-response curve to ACh before and after L-NMMA responses. However, studies in the coronary circulation of may have detected significant attenuation of the response.
older patients with multiple risk factors for atherosclerosis have shown impairment of metabolic vasodilation [9] .
Mechanisms of impaired NO responsiveness
Further studies will be required to determine whether improvement in endothelial function with cholesterol-low-A number of potential mechanisms have been proposed ering will improve metabolic vasodilation and reduce to explain the observed impairment in NO bioavailability ischemia in advanced disease. 
